TherapeuticsMD Stock Forms Golden Cross, Signaling Potential Bullish Breakout
TherapeuticsMD, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. Despite a year-over-year decline of 24.47%, the company has rebounded with a 36.05% increase year-to-date. Current performance metrics show mixed signals, prompting investor interest in future trading activity.
TherapeuticsMD, Inc., a microcap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a significant technical event known as a Golden Cross. This occurs when a stock's short-term moving average crosses above its long-term moving average, often signaling a potential shift in momentum towards bullish sentiment.Currently, the stock's performance metrics reveal a mixed picture. Over the past year, TherapeuticsMD has seen a decline of 24.47%, contrasting sharply with the S&P 500's gain of 19.89%. However, year-to-date, the company has rebounded with a notable increase of 36.05%, outperforming the S&P 500's 16.3% during the same period.
Despite the recent Golden Cross, the stock's daily performance has dipped by 1.68%, and its weekly performance shows a decline of 10.69%. The technical indicators present a mildly bullish outlook on the MACD and KST, while the Bollinger Bands reflect a mixed sentiment.
Investors will be keen to monitor how this Golden Cross influences future trading activity and whether it can help TherapeuticsMD regain lost ground in a competitive market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
